John L. Clifford

2.5k citations

37 papers · 2.0k indexed · 1 hit paper · h-index 20

Dermatology top 1%
Immunology top 5%
Oncology top 5%
- Cytokine Signaling Pathways and Interactions 7
Immunology and Allergy top 10%
Cancer Research top 10%
- NF-κB Signaling Pathways 5
Physiology
- Pain Mechanisms and Treatments 9
Surgery
- Bladder and Urothelial Cancer Treatments 5
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 4
- Retinoids in leukemia and cellular processes 3
Pediatrics, Perinatology and Child Health
- Pediatric Pain Management Techniques 4
Rehabilitation
- Wound Healing and Treatments 3

Co-authors: John DiGiovanni Hideki Chiba Pierre Chambon Daniel Metzger Shigetoshi Sano Steve Carbajal Keith Syson Chan Kaoru Kiguchi
Cited by: Dermatology Immunology Oncology
Journals: Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (1 paper)
Partner nations: United States Australia France

In The Last Decade

John L. Clifford

36 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by John L. Clifford

Since Specialization

Citations

This map shows the geographic impact of John L. Clifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Clifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Clifford more than expected).

Fields of papers citing papers by John L. Clifford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Clifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Clifford. The network helps show where John L. Clifford may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John L. Clifford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John L. Clifford Line = papers co-authored together John L. Clifford links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antinociceptive effects of pluronic lecithin organo (PLO)-opioid gels in rats with thermal injury Burns ·John L. Clifford,Robert J. Christy,Bopaiah P. Cheppudira	2017	4
2	Progress of clinical practice on the management of burn-associated pain: Lessons from animal models Burns ·Matthew K. McIntyre,John L. Clifford,Christopher V. Maani,David M. Burmeister	2016	22
3	Tetrodotoxin suppresses thermal hyperalgesia and mechanical allodynia in a rat full thickness thermal injury pain model Neuroscience Letters ·Margaux M. Salas,Matthew K. McIntyre,Lawrence N. Petz,Walter Korz,Donald Wong,John L. Clifford	2015	27
4	Preemptive perineural bupivacaine attenuates the maintenance of mechanical and cold allodynia in a rat spinal nerve ligation model BMC Anesthesiology ·John L. Clifford,Alberto Mares,Jacob J. Hansen,Dayna L. Averitt	2015	3
5	Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory pain Biomedical Reports ·Bopaiah P. Cheppudira,Thomas H. Garza,Lawrence N. Petz,John L. Clifford,Marcie Fowler	2015	15
6	Prehospital and En Route Analgesic Use in the Combat Setting: A Prospectively Designed, Multicenter, Observational Study Military Medicine ·Lawrence N. Petz,Stuart D. Tyner,Ed Barnard,A. Ervin,Alex Mora,John L. Clifford,Marcie Fowler,Vikhyat S. Bebarta	2015	32
7	Anti-nerve growth factor antibody attenuates chronic morphine treatment-induced tolerance in the rat BMC Anesthesiology ·Bopaiah P. Cheppudira,Alex V. Trevino,Lawrence N. Petz,Robert J. Christy,John L. Clifford	2015	6
8	State of the science review The Journal of Trauma: Injury, Infection, and Critical Care ·John L. Clifford,Marcie Fowler,Jacob J. Hansen,Bopiah Cheppudira,Jennifer E. Nyland,Margaux M. Salas,Laura L. McGhee,Lawrence N. Petz,Dayna R. Loyd	2014	15
9	Biological activities of fusarochromanone: a potent anti-cancer agent BMC Research Notes ·Elahe Mahdavian,Phillip Palyok,Steven Adelmund,Tara Williams-Hart,Brian D. Furmanski,Yoon-Jee Kim,Ying Gu,Mansoureh Barzegar,Yang Wu,Kaustubh N. Bhinge,Gopi K. Kolluru,Quincy Quick,Yu Liu,Christopher G. Kevil,Brian A. Salvatore,Shile Huang,John L. Clifford	2014	13
10	Curcumin: a novel therapeutic for burn pain and wound healing Expert Opinion on Investigational Drugs ·Bopaiah P. Cheppudira,Marcie Fowler,Laura L. McGhee,Angie Greer,Alberto Mares,Lawrence N. Petz,David I. Devore,Dayna R. Loyd,John L. Clifford	2013	69
11	Role of α6β4 Integrin in Cell Motility, Invasion and Metastasis of Mammary Tumors Current Protein and Peptide Science ·Jun Chung,John L. Clifford,Young Hwa Soung,Hyea Jin Gil	2011	20
12	HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop BMC Cancer ·Zanobia Syed,Weihong Yin,Kendall Hughes,Jennifer N. Gill,Runhua Shi,John L. Clifford	2011	52
13	The Promise of Natural Products for Blocking Early Events in Skin Carcinogenesis Cancer Prevention Research ·John L. Clifford,John DiGiovanni	2010	13
14	Identification of Genes Correlated with Early-Stage Bladder Cancer Progression Cancer Prevention Research ·Randolph Stone,Anita L. Sabichi,Jennifer Gill,I-ling Lee,Patrick A. Adegboyega,Michael S. Dai,Raja Loganantharaj,Marjan Trutschl,Urška Cvek,John L. Clifford	2010	23
15	Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression BMB Reports ·Young-Hwa Soung,John L. Clifford,Jun Chung	2010	73
16	Identification of genes involved in early stage bladder pathogenesis Cancer Epidemiology and Prevention Biomarkers ·Anita L. Sabichi,Jennifer Roberts,I-ling Lee,Urška Cvek,Marjan Trutschl,John L. Clifford	2007	1
17	Novel derivatives of fusarochromanone: potential therapeutic compounds Cancer Research ·Elahe Mahdavian,Brian A. Salvatore,John L. Clifford	2007	1
18	Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis Oncogene ·Keith Syson Chan,Shigetoshi Sano,Ken Kataoka,Erika L. Abel,Steve Carbajal,Linda Beltrán,John L. Clifford,Mary Peavey,Jianjun Shen,John DiGiovanni	2007	89
19	Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse modelbreakdown → Nature Medicine ·Shigetoshi Sano,Keith Syson Chan,Steve Carbajal,John L. Clifford,Mary Peavey,Kaoru Kiguchi,Satoshi Itami,Brian J. Nickoloff,John DiGiovanni	2004	592
20	Detection of Nuclear Retinoic Acid Receptor mRNA in Histological Tissue Sections Using Nonradioactive In Situ Hybridization Histochemistry Diagnostic Molecular Pathology ·Xiao-Chun Xu,John L. Clifford,W K Hong,Reuben Lotan	1994	30

About John L. Clifford

John L. Clifford is a scholar working on Immunology and Allergy, Dermatology and Rehabilitation, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (9 papers), Cytokine Signaling Pathways and Interactions (7 papers), Bladder and Urothelial Cancer Treatments (5 papers), NF-κB Signaling Pathways (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Pediatric Pain Management Techniques (4 papers), Wound Healing and Treatments (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Dermatology (343 citations), Immunology (611 citations) and Oncology (591 citations). John L. Clifford has collaborated with scholars based in United States, Australia and France. Frequent co-authors include John DiGiovanni, Hideki Chiba, Pierre Chambon, Daniel Metzger, Shigetoshi Sano, Steve Carbajal, Keith Syson Chan, Kaoru Kiguchi, Mary Peavey and Satoshi Itami. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact